• Molecular NameEstropipate
  • SynonymEstropipate (usp); OGEN; Ogen (TN); Ogen 2; 5
  • Weight436.573
  • Drugbank_IDDB04574
  • ACS_NO7280-37-7
  • Show 2D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)0.37
  • pkaN/A
  • LogD (pH=7, predicted)0.37
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-1.69
  • LogSw (predicted, AB/LogsW2.0)0.22
  • Sw (mg/ml) (predicted, ACD/Labs)7.19
  • No.of HBond Donors0
  • No.of HBond Acceptors5
  • No.of Rotatable Bonds4
  • TPSA78.05
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA form of estrogen sold under the brand names Ogen and Ortho-Est.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A